Labcorp stock gains 1.63 percent as Q2 growth holds
Published on 09/24/2026 at 23:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Labcorp stock (NYSE: LH) stood at USD 308.95 on September 24, 2026 at 4:00 p.m. ET, up 1.63 percent on the session. The move followed a quarter in which revenue rose 5.8 percent to USD 3.7 billion and adjusted EPS increased 14.9 percent to USD 4.99.
Q2 growth reaches both segments
According to Fortune, Labcorp reported Q2 2026 adjusted operating income of USD 589 million, compared with USD 532 million in Q2 2025. The adjusted operating margin reached 15.8 percent, up 70 basis points from 15.1 percent.
Diagnostics generated USD 2.9 billion in Q2 2026 revenue, up 5.5 percent year over year, while Biopharma Laboratory Services produced USD 836 million, up 6.5 percent. The segment mix matters because it shows growth across Labcorp's established testing business and its pharmaceutical services unit.
Guidance rises with the earnings base
Labcorp's full-year 2026 guidance calls for enterprise revenue growth of 5.4 percent to 6.3 percent and adjusted EPS of USD 18.10 to USD 18.55. The midpoint of the EPS range increased by USD 0.30, while the revenue midpoint rose by USD 42 million, according to Fortune.
The company also reported USD 314 million in Q2 2026 free cash flow, compared with USD 543 million a year earlier. That contrast gives investors a second performance marker: earnings growth accelerated, while cash generation was lower during the quarter because of working-capital timing and planned capital spending.
Analyst target sits above the quote
On September 21, 2026, Truist Financial raised its Labcorp price target from USD 350 to USD 365 and maintained a Buy rating, as reported by MarketBeat. The new target is 18.15 percent above the September 24 price, adding a clear valuation reference to the earnings discussion.
Stock remains below yearly high
At USD 308.95, Labcorp stock was 9.61 percent below its 52-week high of USD 341.80 on September 24, 2026. The reference price was on the NYSE, while the company reported a market capitalization of USD 25.33 billion.
Labcorp stock at a glance
- Company: Labcorp Holdings Inc.
- Ticker: LH
- Trading venue: NYSE
- Price (as of September 24, 2026, 4:00 p.m. ET): USD 308.95
- Market capitalization: USD 25.33 billion (as of September 24, 2026)
- 52-week range: USD 244.52-341.80 (as of September 24, 2026)
- Sector / Industry: Healthcare / Medical Diagnostics and Research
